14 Mar 2023 Oxurion provides update on recruitment for KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema and announces Board changes Member news
09 Mar 2023 Cancer Research UK signs multi-project collaboration with UCB to advance oncology antibody candidates Member news
06 Mar 2023 Mithra announces promising topline safety results from Donesta® Phase 3 Study in North America Member news
02 Mar 2023 VIB spin-off Flamingo Therapeutics merges with Dynacure to create leading RNA therapeutics company in oncology Member news
02 Mar 2023 CMT Research Foundation (USA) collaborates with Augustine Therapeutics on new therapy against Charcot-Marie-Tooth disease Member news
02 Mar 2023 Mithra announces compelling initial preclinical data in its research collaboration on novel tyrosine kinase inhibitors with BCI Pharma Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
